TradeOrgs
  • Stocks
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%
RELIANCE₹1,304.00▼ 0.70%TCS₹2,093.50▼ 6.61%HDFCBANK₹801.05▲ 6.29%ICICIBANK₹1,411.40▲ 13.64%INFY₹1,047.20▼ 14.35%HINDUNILVR₹2,201.20▲ 5.29%ITC₹289.95▲ 4.68%SBIN₹1,040.00▲ 7.17%BHARTIARTL₹1,910.40▲ 4.73%KOTAKBANK₹396.75▲ 4.13%LT₹4,026.60▲ 1.86%AXISBANK₹1,342.10▲ 6.92%ASIANPAINT₹2,737.80▲ 2.83%MARUTI₹14,366.00▲ 10.13%AAPL$308.63▼ 2.08%MSFT$390.49▼ 11.52%GOOGL$359.91▼ 0.54%AMZN$242.67▼ 5.40%NVDA$194.83▼ 12.56%META$582.90▼ 2.46%TSLA$393.45▼ 7.15%BRK-B$507.78▲ 7.69%JPM$334.47▲ 11.13%V$362.13▲ 14.12%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← All stocks

🇺🇸ANIP

ANI Pharmaceuticals, Inc. - Common Stock

NASDAQ
$86.03
▲ $11.38 (+15.2%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 02 Jul 2026
H $87.76L $70.15+6.6%
$87.76$84.24$80.72$77.19$73.67$70.15$86.03
RSI (14)
Intraday · 15-minStrong buy+45RSI 62UptrendMACD Bullishfor day-trading context — not advice

Technical signal

Strong buy+50
RSI (14)63
oversold 30overbought 70
Trend
Uptrend
MACD
Bullish
Bollinger
Above upper band
vs 20-day
above
vs 50-day
above
vs 200-day
above
Support
$76.00
Resistance
$86.13
  • Price is above its 50-day average (medium-term uptrend).
  • Price is above its 200-day average (long-term uptrend).

Signal backtest · 2025-09-29 → 2026-07-02

Strategy return
-8.2%
Buy & hold
-6.4%
Trades
8
Win rate
25%

$100,000.00 invested would be worth $91,847.97 (-8.2%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About ANI Pharmaceuticals, Inc.· Drug Manufacturers - Specialty & Generic

source: yahoo

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
970
Headquarters
Baudette, United States
www.anipharmaceuticals.com ↗

Fundamentals

source: yahoo
Market cap
$1.96B
P/E
22.0
P/B
3.3
EPS
$3.91
Div yield
—
Profit margin
10.0%
ROE
18.3%
Debt / Equity
1.12
Beta
0.43
52-week range
$62.61 – $99.50
52-week low · $62.6163% of rangehigh · $99.50

Fundamental data is informational only — not investment advice.

Recent news

News sentiment:▲ Positive2↑ · 1↓ · 5–
  • How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks?— Neutral
    Barchart · 19 Jun 2026
  • Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?▲ Positive
    Zacks · 10 Jun 2026
  • ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push— Neutral
    Zacks · 10 Jun 2026
  • 2 Cash-Producing Stocks to Research Further and 1 Facing Challenges
  • Price is above the upper Bollinger Band (stretched to the upside).
  • Educational technical indicators — not investment advice. TradeOrgs does not place trades.

    — Neutral
    StockStory · 09 Jun 2026
  • How ANI’s Estradiol Gel Recall at ANI Pharmaceuticals (ANIP) Has Changed Its Quality-Control Investment Story▼ Negative
    Simply Wall St. · 05 Jun 2026
  • Ani (ANIP) Q1 2026 Earnings Call Transcript— Neutral
    Motley Fool · 01 Jun 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.